Chilton Capital Management’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-399
Closed -$5.86K 552
2023
Q1
$5.86K Buy
+399
New +$6.06K ﹤0.01% 485
2022
Q3
Sell
-689
Closed -$11K 311
2022
Q2
$11K Buy
+689
New +$11K ﹤0.01% 453
2022
Q1
Sell
-689
Closed -$12K 315
2021
Q4
$12K Buy
+689
New +$12K ﹤0.01% 472

Other funds holding DIAX

Chilton Capital Management's DIAX Position: Q2 2023 in Review

Chilton Capital Management sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q2 2023, closing a stake of 399 shares — an estimated $5.86K sold.

Chilton Capital Management first reported a position in DIAX in Q4 2021 and held it in 3 quarters. The position peaked at $12K in Q4 2021. 82 funds tracked by Wall St. Rank hold DIAX as of Q2 2023.

  • Chilton Capital Management reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q2 2023 after selling out during the quarter.
  • Chilton Capital Management sold 399 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q2 2023, an estimated $5.86K.
  • Chilton Capital Management first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q4 2021 and held it in 3 quarters.
  • Chilton Capital Management's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $12K in Q4 2021.
  • 82 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q2 2023.

Based on Chilton Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.